Lo Giudice G, Iannello G, Terranova A, Lo Giudice R, Pantaleo G, Cicciù M
Medical Sciences and Stomatology Department, School of Dentistry, University of Messina, Via Consolare Valeria, 98100 Messina, Italy.
Human Pathology Department, School of Dentistry, University of Messina, Via Consolare Valeria, 98100 Messina, Italy.
Int J Dent. 2015;2015:261652. doi: 10.1155/2015/261652. Epub 2015 Sep 16.
Aim. The aim of this study was to assess the success and the survival rate of dental implants placed in augmented bone after sinus lifting procedures. Material and Methods. 31 patients were mainly enrolled for a residual upper jaw crest thickness of 3 mm. CBCT scans were performed before and after the augmentation technique and at the follow-up appointments, at 3, 6, 12, 24, and up to 60 months. The follow-up examination included cumulative survival rate of implants, peri-implant marginal bone loss, and the height of sinus floor augmentation. Results. This retrospective study on 31 patients and 45 implants later inserted in a less than 3 mm crest showed excellent survival rates (99.5%), one implant was lost before loading due to an acute infection after 24 days, and two implants did not osteointegrate and were removed after 3 months. The radiological evaluation showed an average bone loss of 0.25 mm (±0.78 mm) at the first follow-up appointment (3 months) up to 0.30 mm (±1.28 mm) after 60-month follow-up. Conclusion. In this study it was reported how even in less than 3 mm thick crest a transcrestal technique can predictably be used with a long-term clinical and radiological outcome, giving patients excellent stability of the grafted material and healthy clinical results.
目的。本研究的目的是评估在鼻窦提升术后植入增骨部位的牙种植体的成功率和存活率。材料与方法。主要纳入了31例上颌嵴剩余厚度为3毫米的患者。在增骨技术前后以及随访时进行CBCT扫描,随访时间为3、6、12、24个月直至60个月。随访检查包括种植体的累积存活率、种植体周围边缘骨丢失以及鼻窦底提升的高度。结果。这项对31例患者和后来植入不足3毫米嵴中的45颗种植体的回顾性研究显示出优异的存活率(99.5%),一颗种植体在加载前因24天后的急性感染而丢失,两颗种植体未骨整合并在3个月后被取出。放射学评估显示,在首次随访(3个月)时平均骨丢失为0.25毫米(±0.78毫米),至60个月随访后为0.30毫米(±1.28毫米)。结论。在本研究中报告了,即使在上颌嵴厚度不足3毫米的情况下,穿嵴技术仍可预测地用于获得长期临床和放射学结果,为患者提供移植材料的优异稳定性和健康的临床结果。